Severe Lactic Acidosis in a Critically Ill Child: Think About Thiamine! A Case Report

Clémence Didisheim1, Diana Ballhausen2, Marie-Louise Choucair3

  • 1Department of Pediatrics, Pediatric Intensive Care Unit, University Hospital and Medicine and Biology Faculty of Lausanne, Lausanne, Switzerland.

Insights

A teenager with leukemia developed severe lactic acidosis during chemotherapy. Thiamine supplementation rapidly normalized lactate levels, highlighting its importance in critically ill pediatric patients.

Area of Science:

  • Biochemistry
  • Pediatric Critical Care
  • Nutritional Science

Background:

  • Leukemia patients undergoing chemotherapy are at risk for nutritional deficiencies.
  • Parasitic infections can complicate management and increase nutritional demands.
  • Severe illness can precipitate metabolic derangements, including lactic acidosis.

Observation:

  • A teenage leukemia patient on maintenance chemotherapy presented with parasitic infection and required parenteral nutrition.
  • The patient developed refractory shock, necessitating extracorporeal membrane oxygenation.
  • Despite hemodynamic support, worsening lactic acidosis persisted until thiamine administration.

Findings:

  • Thiamine supplementation led to rapid normalization of lactic acidosis within 12 hours.
  • Thiamine is a crucial coenzyme for aerobic glycolysis; deficiency impairs this pathway.
  • Lactate accumulation occurred due to a shift towards anaerobic glycolysis secondary to thiamine deficiency.

Implications:

  • Thiamine deficiency should be considered in pediatric patients with unexplained lactic acidosis, especially those with risk factors.
  • Early recognition and supplementation of thiamine can be life-saving in critically ill children.
  • This case underscores the importance of comprehensive nutritional assessment and management in immunocompromised pediatric patients.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Disorders of Acid-Base Balance01:29

Disorders of Acid-Base Balance

The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and HCO3−  values are examined to...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...